In-Use Stability of Oncology Antibody Therapeutics: Risks, Analytical Strategies, and Regulatory Perspectives

Carlos Victor Montefusco-Pereira

Open source

DOI
10.5731/pdajpst.2026-000046.1
Published
2026-10-23
Container
PDA Journal of Pharmaceutical Science and Technology
Publisher
Parenteral Drug Association, Inc.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5731/pdajpst.2026-000046.1,
  title = {In-Use Stability of Oncology Antibody Therapeutics: Risks, Analytical Strategies, and Regulatory Perspectives},
  author = {Carlos Victor Montefusco-Pereira},
  year = {2026},
  journal = {PDA Journal of Pharmaceutical Science and Technology},
  doi = {10.5731/pdajpst.2026-000046.1},
  url = {https://doi.org/10.5731/pdajpst.2026-000046.1}
}

RIS

TY  - JOUR
TI  - In-Use Stability of Oncology Antibody Therapeutics: Risks, Analytical Strategies, and Regulatory Perspectives
AU  - Carlos Victor Montefusco-Pereira
PY  - 2026
JO  - PDA Journal of Pharmaceutical Science and Technology
DO  - 10.5731/pdajpst.2026-000046.1
UR  - https://doi.org/10.5731/pdajpst.2026-000046.1
ER  - 

APA

Montefusco-Pereira, C. V. (2026). In-Use Stability of Oncology Antibody Therapeutics: Risks, Analytical Strategies, and Regulatory Perspectives. PDA Journal of Pharmaceutical Science and Technology. https://doi.org/10.5731/pdajpst.2026-000046.1

Source records